Author | Scott J. Antonia, MD, PhD | OncLive

Author | Scott J. Antonia, MD, PhD

Articles

Dr. Antonia on Investigational Immunotherapy Combinations in Stage III NSCLC

June 21, 2019

Video

Scott J. Antonia, MD, PhD, instructor, Duke University School of Medicine, member, Duke Cancer Institute, discusses investigational immunotherapy combinations in stage III non–small cell lung cancer (NSCLC).

Dr. Antonia on the Promise of Immunotherapy in NSCLC

May 29, 2019

Video

Scott J. Antonia, MD, PhD, instructor, Duke University School of Medicine, member, Duke Cancer Institute, discusses the promise of immunotherapy in patients with non–small cell lung cancer.

Phase II Clinical Trial of Intratumoral Dendritic Cells Injections and Neoadjuvant Radiotherapy in Resectable Soft Tissue Sarcomas

February 22, 2018

Article

Neoadjuvant radiation with dendritic cell injections has the potential to be safe, effective, and immunogenic in high-grade soft tissue sarcoma and needs to be confirmed in randomized larger clinical trials.

Dr. Antonia on Emerging Immunotherapies in Lung Cancer

December 02, 2016

Video

Scott J. Antonia, MD, PhD, chair of the Department of Thoracic Oncology at Moffit Cancer Center, discusses immunotherapies that are emerging in the field of lung cancer.

x